Assessment of safety and efficacy of biphasic human insulin IU 100 to EX1000 on glycaemic control in subjects with type 2 diabetes
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs EX 1000; Insulin suspension isophane/insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 13 Sep 2012 Planned number of patients changed from 400 to 480.
- 25 Aug 2011 New source identified and integrated (Clinical Trial Registry - India, CTRI2008-091-000035).